Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Similar documents
Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017

MEDICAL ASSISTANCE BULLETIN

PA Start Date Therapeutic Class P&T Review Date 7/1/13 TOP$ (Single Drug Reviews) include:

CONTENTS SECTION 1 SECTION

Kentucky Department for Medicaid Services. Drug Review Options

Appropriate Use & Safety Edits

New Product to Market: Trelegy Ellipta Magellan Health, Inc. All rights reserved.

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual. Vitamin and Mineral Products. Effective Date. November 2017

Drug Classifications

Kentucky Department for Medicaid Services Pharmacy and Therapeutics Advisory Committee Recommendations

Kentucky Department for Medicaid Services. Drug Review Options

Michigan Pharmacy and Therapeutics Committee September 11, Minutes

Michigan Department of Health and Human Services Pharmacy and Therapeutics Committee

New Product to Market: Lonhala Magnair

Tips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs. June 5, 2015

Drug Classification and Pharmacologic Actions

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,

Alabama Medicaid Preferred Drug and Prior Authorization Program

Kentucky Department for Medicaid Services Pharmacy and Therapeutics Advisory Committee Recommendations

Pharmacology 260 Online Course Schedule Summer 2015

MEDICAL ASSISTANCE BULLETIN

Drug Classifications

Quarterly pharmacy formulary change notice

PHARMACY BENEFITS MANAGER

MEDICAL ASSISTANCE BULLETIN

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012

$250 (Deductible does not apply to Tier 1 and Tier 2) $500 (Deductible does not apply to Tier 1 and Tier 2)

Quarterly pharmacy formulary change notice

Anatomical Therapeutic Chemical Classification (ATC) & And Defined Daily Dose (DDD) Principles for classifying and quantifying drug use

Michigan Pharmacy and Therapeutics Committee

STOPP START Toolkit Supporting Medication Review in the Older Person

PATIENT-IMPACT SCORECARD

FLORIDA 2017 EHB BENCHMARK PLAN

Quarterly pharmacy formulary change notice

About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.

Medicaid Perspective

Quarterly pharmacy formulary change notice

CHRONIC MEDICATION PROGRAMME INCLUDES PRESCRIBED MINIMUM BENEFIT CHRONIC DISEASE LIST (CDL)

Quarterly pharmacy formulary change notice

Drugs Categories. 4. Which suffix do erectile dysfunction generic drug names often end with?

2019 List of Covered Drugs

Kentucky Department for Medicaid Services Drug Review and Options for Consideration

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Scope and Methodology Size and Growth of the Market Issues and Trends Affecting the Rx-to-OTC Switches Market Leading Competitors

Primary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other

Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis.

TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE

Essentials for Medication Safety

New Product to Market: Lucemyra Magellan Health, Inc. All rights reserved.

Quarterly pharmacy formulary change notice

Kentucky Department for Medicaid Services Pharmacy and Therapeutics Advisory Committee Recommendations

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

PHARMACY TIMES BY IEHP PHARMACEUTICAL SERVICES DEPARTMENT August 23, 2012

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List

Prescription Drugs North Carolina Policies. Carol Steckel, MPH Medicaid Director

Coverage Period: 01/01/ /31/2018 Coverage for: Individual and/or Family Plan: Healthy Rewards HSA

XOLAIR (omalizumab) Prior Authorization

Kentucky Department for Medicaid Services Drug Review and Options for Consideration

Pharmacy Prep. Qualifying Pharmacy Review

Drug Therapy Management

Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis.

Secretary for Health and Family Services Selections for Preferred Products

Mail Service Pharmacy

2018 Travelers Prescription Drug Plan High Deductible + HSA Plan

Quarterly pharmacy formulary change notice

Pharmacy Benefit Management

Prescription Audit carried out at the Pharmacy Practice Centre of the University of Nairobi between June and November 2004

WITBANK COALFIELDS MEDICAL AID SCHEME (WCMAS) CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

Alabama Medicaid Preferred Drug and Prior Authorization Program

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

Community Paramedic Training Program

Nclex para la Enfermera Hispana

CME/CE POSTTEST CME/CE QUESTIONS

2017 URAC PHARMACY BENEFIT MANAGEMENT PERFORMANCE MEASUREMENT: AGGREGATE SUMMARY PERFORMANCE REPORT

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

STEP THERAPY ALGORITHMS PUP Select Formulary

Coventry Health Care of Georgia, Inc.

CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

Step Therapy Criteria

Pharmacy Orientation PP150. Associate professor of Pharmaceutics Faculty of Pharmacy-Mansoura University

Covered California Formulary Analysis of Top 100 Drugs and Select Classes Prepared for the California HealthCare Foundation Avalere.

Disease Management. Measures At A Glance

Contents. SECTION 1 General Pharmacology. SECTION 2 Drugs Affecting Autonomic Nervous System

Coverage Period: Coverage for: Plans: This is only a summary of your GatorCare pharmacy benefits. Coinsurance: you your Dependent Copayment: you

San Francisco Health Care Accountability Ordinance Minimum Standards Effective January 1, 2019

MEASURE STEWARD Pharmacy Quality Alliance (PQA) D ATA SOURCE Enrollment; U R A C DOMAIN Engagement & Experience of Care

CHAPTER II DRUG INDUCED PULMONARY DISEASES. BY J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY

proposed set to a required subset of 3 to 5 measures based on the availability of electronic

Course Title Systematic Pharmacology I

Quarterly pharmacy formulary change

Plan Change Alert. New Market Priced Drug (MPD) Program Effective 11/1/2016. Alaska United Food and Commercial Workers Trust

Drug Prior Authorization Guideline NUCALA (mepolizumab)

Table 1: Guideline data collection

Background. Background. Background 3/14/2014. Conflict of Interest Statement:

STOPP and START criteria October 2011

CYTOKINE AND CAM ANTAGONIST UTILIZATION IN MISSISSIPPI MEDICAID

Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists

Medicare Parts B/D Coverage Issues

Transcription:

Texas Vendor Drug Program Formulary Drug Index File Layout Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018 The Vendor Drug Program provides a weekly update of resource data available for download from txvendordrug.com/resources/downloads. The downloadable formulary file is of variable field length, meaning the field length varies depending on the data. Column headers are included as the first line, and each subsequent line is a row of data whose items have been separated by a comma. Values are enclosed between double quotes when values are present, but double quotes will not be applied to fields when no character value exists. Null values are not populated with spaces. i

Drug_Generic Generic Name of drug. 5 Drug_HTW_code Drug_limit_fp Drug_limit_ds Drug_limit_ppg Drug is active on Healthy Texas Women (HTW) Program formulary. Identifies whether NDC is "family planning" drug. Identifies whether NDC is "diabetic supply" drug. Identifies whether NDC has "premium preferred generic" (PPG) pricing. Drug_limit_refill Most medications must have at least 75 percent of the prescribed supply filled before obtaining a refill. Certain controlled substances must have 90 percent of the supply filled. Affects only claims paid by VDP: FFS Medicaid, CSHCN, HTW, and KHC programs. Drug_NDC Drug_Descr 11-digit National Drug Code (NDC) Number. First Databank (FDB) label name of drug. 11 5 Drug_Pkg Package size. 12 ZZZZZZ.99999 1

Drug_Unit Unit of measure. 2 GM = Gram ML - Milliliter EA = Each Drug_40B Current 40B price. 12 ZZZZZZ.99999 Drug_med_EffDate Drug_med_EndDate Drug_Med_Code Drug_CMP_V Drug_Med_Comment Effective date of drug on Medicaid formulary. Termination date of drug on Medicaid formulary. Drug is active on Medicaid formulary. Drug is only available for multi-ingredient compound Medicaid claims. Comment for Medicaid formulary items. Items with a termination date will appear on this file for 90 days after that termination date. If active in program and "Yes" If active in program and not "No" If not active in program then 0 If drug is Xenical then populate "Xenical FFS PA Form Required" If drug is enzyme then populate "Enzyme FFS PA Form Required" If drug is synagis then populate "Synagis FFS PA Form Required" Refer to txvendordrug.com/formulary/pr ior-authorization/medicaid-ffsforms for forms and program requirements. 2

Drug_chip_EffDate Drug_chip_EndDate Drug_chip_code Drug_CMP_P Drug_cshcn_EffDate Drug_cshcn_EndDate Drug_cshcn_code Drug_CMP_C Effective date of drug on CHIP formulary. Termination date of drug on CHIP formulary. Drug is active on CHIP formulary. Drug is only available for multi-ingredient compound CHIP claims. Effective date of drug on CSHCN formulary. Termination date of drug on CSHCN formulary. Drug is active on CSHCN formulary. Drug is only available for multi-ingredient compound CSHCN claims. Items with a termination date will appear on this file for 90 days after that termination date. If active in program and "Yes" If active in program and not "No" If not active in program then Items with a termination date will appear on this file for 90 days after that termination date. If active in program and "Yes" If active in program and not "No" If not active in program then

Drug_cshcn_comment Drug_khc_EffDate Drug_KHC_EndDate Drug_khc_code Drug_CMP_K Drug_htw_EffDate Comment for CSHCN formulary items. Effective date of drug on KHC formulary. Termination date of drug on KHC formulary. Drug is active on KHC formulary. Drug is only available for multi-ingredient compound KHC claims. Effective date of drug on HTW formulary. 0 If drug is for cystic fibrosis treatment, growth hormone treatment, or synagis, then populate "'CSHCN PA Form Required" If drug is for HIV treatment, family planning, or pulmonary hypertension treatment, then populate "Refer to program requirements" Refer to txvendordrug.com/formulary/pr ior-authorization/cshcn for forms and program requirements. Items with a termination date will appear on this file for 90 days after that termination date. If active in program and compound only then value = "Yes" If active in program and not compound only then value = "No" If not active in program then 4

Drug_htw_EndDate Drug_legend_status Drug_PDL_pa_required Drug_pdl_EffDate Drug_MKID Drug_Clinical_pa_requir ed Drug_Retail Termination date of drug on HTW formulary. Identifies whether drug is Legend or Over the Counter. Non-preferred (PDL) prior authorization required. Non-preferred (PDL) prior authorization effective date. Preferred prior authorization therapeutic class ID. Clinical prior authorization required for Medicaid. Current acquisition cost for VDP-identified retail pharmacies. Items with a termination date will appear on this file for 90 days after that termination date. 21 Over the counter Prescription required If active in Medicaid and PDL prior authorization required, then value = "Yes" If active in Medicaid and no PDL prior authorization required, then value = "No" If not active in Medicaid then 4 See field Drug_MKID_Desc for values. If active in Medicaid and one or more clinical prior authorization(s) required, then value = "Yes" If active in Medicaid and no clinical prior authorization(s) required, then value = "No" If not active in Medicaid then 12 ZZZZZZ.99999 5

Drug_Retail_EffDate Drug_LTC Drug_LTC_EffDate Drug_SPC Drug_SPC_EffDate Drug_VAC Drug_VAC_EffDate Effective date of retail pharmacy drug pricing. Current acquisition cost for VDP-identified long term care pharmacies. Effective date of LTC pharmacy drug pricing. Current acquisition cost for VDP-identified specialty pharmacies. Effective date of specialty pharmacy drug pricing. VDP Acquisition Cost, for when NDC does not have retail, LTC, or specialty.pricing Effective date of drug pricing. 12 ZZZZZZ.99999 12 ZZZZZZ.99999 12 ZZZZZZ.99999 6

Drug_MKID_Desc PDL therapeutic class description. 50 0 = Not assigned 1 = H. Pylori Treatment 2 = Ophthalmics For Allergic Conjunctivitis = BPH Treatments 4 = Platelet Aggregation Inhibitors 6 = Bladder Relaxant Preparations 7 = Stimulants and Related Agents 8 = Antidepressants, Ssris 9 = Hypoglycemics, TZD 10 = Ulcerative Colitis Agents 11 = Alzheimer's Agents 1 = Ophthalmics, Anti- Inflammatories 14 = Growth Hormone 15 = Antiparkinson's Agents 17 = Angiotensin Modulator Combinations 18 = Macrolides/Ketolides 19 = Intranasal Rhinitis Agents 21 = Antimigraine Agents, Triptans 22 = Hypoglycemics, Meglitinides 2 = Immune Globulins 25 = Antivirals, Oral 27 = Antipsychotics 28 = Fluoroquinolones, Oral 29 = Hypoglycemics, Insulin and Related Agents 0 = Antihistamines, Minimally Sedating 1 = Antidepressants, Other = Glucocorticoids, Inhaled 4 = Immunomodulators, Atopic Dermatitis 6 = Ophthalmic Antibiotic- Steroid Combinations 7

7 = Bronchodilators, Beta Agonist 8 = Erythropoiesis Stimulating Proteins 40 = Smoking Cessation 42 = Leukotriene Modifiers 45 = Calcium Channel Blockers 46 = Cephalosporins and Related Antibiotics 47 = Proton Pump Inhibitors 51 = Otic Antibiotics 52 = Phosphate Binders 54 = Sedative Hypnotics 55 = Lipotropics, Other 58 = Ophthalmic Antibiotics 59 = Nsaids 60 = Bone Resorption Suppression And Related Agents 61 = Antifungals, Topical 6 = Lipotropics, Statins 64 = Hepatitis C Agents 68 = Anticoagulants 69 = Antifungals, Oral 70 = Beta-Blockers 71 = Cytokine And Cam Antagonists 84 = Androgenic Agents 85 = Antiemetic/Antivertigo Agents 88 = Ophthalmics, Glaucoma Agents 98 = COPD Agents 104 = Acne Agents, Topical 108 = Pancreatic Enzymes 109 = Analgesics, Narcotics Short 110 = Analgesics, Narcotics Long 111 = Hypoglycemics, Incretin Mimetics/Enhancers 11 = Angiotensin Modulators 8

114 = Antibiotics, Topical 115 = Antibiotics, GI 116 = Skeletal Muscle Relaxants 118 = Steroids, Topical Low 119 = Steroids, Topical Medium 120 = Steroids, Topical High 121 = Steroids, Topical Very High 122 = Antiparasitics, Topical 12 = Antivirals, Topical 124 = Antibiotics, Vaginal 145 = Opiate Dependence Treatments 146 = Lincosamides/Oxazolidinones/St reptogramins 148 = Colony Stimulating Factors 150 = Otic Anti-Infectives & Anesthetics 166 = Antihypertensives, Sympatholytics 168 = Glucocorticoids, Oral 171 = PAH Agents, Oral And Inhaled 182 = Cough and Cold, Cold 18 = Cough and Cold, Narcotic 184 = Cough and Cold, Non- Narcotic 197 = Progestins for Cachexia 198 = Bile Salts 209 = Penicillins 21 = Tetracyclines 229 = Immunosuppressives, Oral 21 = Antihyperuricemics 22 = Neuropathic Pain 28 = Epinephrine, Self- Injected 240 = Antibiotics, Inhaled 24 = Prenatal Vitamins 9

501 = HAE Treatments 506 = Iron, Oral 54 = Irritable Bowel Syndrome 55 = Hypoglycemics, SGLT2 57 = Antimigraine Agents, Other ID Drug_med_EndReason Drug_chip_EndReason Drug_cshcn_EndReason Drug_khc_EndReason 11-digit National Drug Code (NDC) Number. Drug termination reason from Medicaid. Drug termination reason from CHIP. Drug termination reason from CSHCN program. Drug termination reason from KHC program. 11 50 50 50 50 10